Device Bone Substitute

Tornier Perform Reversed Augmented Glenoid

Payments companies reported to CMS as associated with Tornier Perform Reversed Augmented Glenoid. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.6Massociated payments (2023-2025)
474clinicians with associated payments
1company reporting

By year

2023 $397K
2024 $975K
2025 $201K

Payments reported as associated with Tornier Perform Reversed Augmented Glenoid, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthopaedic Surgery $1.2M
Sports Medicine (Orthopaedic Surgery) $323K
Adult Reconstructive Orthopaedic Surgery $36K
Hand Surgery $14K
Orthopaedic Trauma $3,856
Physician Assistant $1,471

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Tornier Perform Reversed Augmented Glenoid

These are the largest totals companies reported as associated with Tornier Perform Reversed Augmented Glenoid. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Mark Mighell Temple Terrace, FL Orthopaedic Surgery $95,192.61
Robert Tashjian Salt Lake City, UT Orthopaedic Surgery $91,589.30
James Gregory Houston, TX Sports Medicine (Orthopaedic Surgery) $84,240.00
Jay Keener Saint Louis, MO Orthopaedic Surgery $83,510.00
Jon Warner Boston, MA Orthopaedic Surgery $71,665.50
Joaquin Sanchez-Sotelo Rochester, MN Orthopaedic Surgery $68,085.00
Vahid Entezari Philadelphia, PA Orthopaedic Surgery $64,125.00
Benjamin Service Orlando, FL Orthopaedic Surgery $47,697.99
Catherine Fedorka Camden, NJ Orthopaedic Surgery $42,922.16
Brent Morris Lexington, KY Orthopaedic Surgery $39,518.06

Prescribed Tornier Perform Reversed Augmented Glenoid?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.